Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 17, Issue 17, pp. 5822-5832
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 5, 2011
- Revision received June 16, 2011
- Accepted June 29, 2011
- Published first July 7, 2011.
Article Versions
- Previous version (July 7, 2011 - 06:52).
- Previous version (August 23, 2011 - 09:32).
- You are viewing the most recent version of this article.
Copyright & Usage
©2011 American Association for Cancer Research.
Author Information
- Carmine Carbone1,
- Tania Moccia1,
- Cihui Zhu2,
- Genni Paradiso1,
- Alfredo Budillon1,
- Paul J. Chiao2,
- James L. Abbruzzese3, and
- Davide Melisi1,3
- Authors' Affiliations: 1Experimental Pharmacology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori–Fondazione “G. Pascale”, Naples, Italy; Departments of 2Molecular and Cellular Oncology and 3Gastrointestinal Medical Oncology/Digestive Diseases, The University of Texas MD Anderson Cancer Center, Houston, Texas
- Corresponding Author:
Davide Melisi, Experimental Pharmacology Unit, Istituto Nazionale per lo studio e la cura dei Tumori–Fondazione “G. Pascale”, via M. Semmola, 80131 Naples, Italy. Phone: 39-081-5903595; Fax: 39-081-5903813; E-mail: d.melisi{at}istitutotumori.na.it; davide.melisi{at}gmail.com
September 2011
Volume 17, Issue 17
Volume 17, Issue 17
Anti-VEGF Treatment–Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype
Jump to section
Advertisement